Inlexisertib Clinical Trials

1 actively recruiting trial across 1 location

Also known as: DCC-3116

Filter by location:

Los Angeles, California1 trial

A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

University of Southern California - Norris Comprehensive Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.